Clinical Trials Information Network

What Clinical Trials Information Network does

Clinical Trials Information Network operates ClinicalTrials.eu, a free, multilingual patient-facing platform that aggregates and curates 9,600+ clinical trials and 9,200+ trial sites across 30+ European countries into a single searchable interface available in 23 European languages. The product is built around an AI-powered natural-language search ("AI Mode") supplemented by structured directories (disease glossary, drug database), specialized portals for rare diseases, pediatric and vaccine trials, and an interactive Leaflet/OpenStreetMap-based site map with city-level granularity. The platform's technical architecture layers harmonized data drawn from CTIS.eu (the EMA registry), national regulators, academic centers, and commercial sponsors atop a multilingual content system and a lightweight LLM-driven matching engine.

The business model is product-led and two-sided: patients access the service free of charge with no registration, while monetization is concentrated on the B2B side through sponsor and site listing/visibility fees, potential data licensing of the harmonized dataset, and referral traffic from 100+ European patient organization partners. GTM is organic — SEO-optimized disease, drug, and location landing pages across 23 country-specific domains, plus patient-organization referral links — with no evident paid acquisition or sales team. The company is privately held, headquartered in Warsaw, Poland (operating entity CTIN Poland), founded in 2024 with 11–50 employees, and has raised a single $1M round in July 2024; ownership, leadership, and detailed financials are undisclosed.

Name

Clinical Trials Information Network

Legal name

European Clinical Trials Information Network

Website

https://Clinicaltrials.eu

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

ClinicalTrials.eu is a free, multilingual patient-facing platform that aggregates 9,600+ clinical trials across 30+ European countries into 23 languages, using AI-powered search and an interactive site map to help patients — particularly those with rare diseases and cancers — discover relevant trial opportunities.

Ownership category

akta.pro rank

Product category

Clinical Trial Discovery Platform

NAICS

Web Search Portals and All Other Information Services (519290)

SIC

Services-Health Services (8000)

akta.pro primary industry

Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

Keywords

• Clinical trial discovery
• Clinical trial registry
• Patient trial matching
• Multilingual health platform
• Clinical trial search

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Sponsor/Site Listings and Visibility: Pharmaceutical companies, contract research organizations (CROs), and clinical trial sites pay for featured placement, sponsor profiles, and enhanced visibility on the platform. The platform mentions dedicated pages for sponsors (e.g., RyVu Therapeutics, Agencja Badań Medycznych) and a 'For Sites and Sponsors' section.
2. Patient Organization Referrals: Referral traffic from patient organizations (100+ partner organizations) may generate referral or affiliate revenue when patients are directed to trial opportunities.
3. Data Licensing / Aggregation Services: Aggregating and harmonizing data from CTIS.eu, national regulators, academic centers, and commercial sponsors creates a curated dataset that could be licensed to pharma companies, CROs, or data analytics firms.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Clinical Trials Information Network operates ClinicalTrials.eu, a free multilingual web platform that enables European patients to search, discover, and match to clinical trials using an AI-powered natural language search engine, an interactive map of 9,200+ trial sites, and structured disease and drug directories. The platform indexes 9,600+ active clinical trials across 30+ European countries, presenting curated data aggregated from CTIS.eu, national regulators, academic centers, and commercial sponsors in 23 European languages.

Product overview

ClinicalTrials.eu operates as a unified multilingual clinical trial search platform that aggregates and presents clinical trial data from public registries across Europe. The core offering is the European Clinical Trials Search Platform, which provides AI-powered search capabilities (AI Mode), supplemented by specialized portals for rare disease treatments, vaccine clinical trials, and pediatric trials. The platform features a drug database and disease glossary, enabling patients to search by disease, drug, or geographic location across 25+ European countries. The service connects patients with over 9,600 clinical trials and 9,200+ clinical sites, delivering information in local languages to overcome European health data language barriers.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 9,600+ clinical trials accessible in 23 European languages
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• EU-X-CT (European X-CT Initiative)coreStrategic or Co-development PartnerEU-X-CT is a European consortium focused on cross-border clinical trial access. ClinicalTrials.eu is listed as a member/organization partner, indicating a strategic alignment on improving patient access to clinical trials across European borders.
• CTIS.eu (Clinical Trial Information System EU)coreTechnology or IntegrationCTIS.eu is the official EU clinical trial registry managed by EMA. ClinicalTrials.eu aggregates and curates data from CTIS.eu, supplementing it with additional sources including academic centers, national regulators, and commercial sponsors.
• RyVu Therapeutics S.A.minorGTM or Marketing PartnerPolish clinical-stage drug discovery company focused on RNA therapeutics. Has a dedicated sponsor profile page on ClinicalTrials.eu, suggesting a commercial listing/visibility partnership.
• Agencja Badań Medycznych (Polish Medical Research Agency)minorGTM or Marketing PartnerPolish government agency funding and overseeing medical research. Listed as a sponsor partner with a dedicated profile page on the platform.
• Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. dr hab. med. Eleonory Reicher (Poland)minorGTM or Marketing PartnerNational Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw. Listed as a clinical trial site partner with a dedicated page on the platform.
• NBScienceminorGTM or Marketing PartnerContract research organization (CRO) listed as a partner on the platform, suggesting a commercial listing relationship.
• 100+ European Patient Organizations (aggregated)coreChannel Partner/ Reseller/ DistributorOver 100 patient organizations across Europe — including rare disease groups (NORD, EB Research Partnership, aHUS Alliance, MPS societies), oncology organizations (breast cancer, lung cancer, colorectal cancer), chronic disease groups (asthma, myasthenia gravis, Crohn's disease), and condition-specific foundations — display the ClinicalTrials.eu logo/link, providing a distributed referral network that drives patient traffic to the platform. Partners include: Angelman Syndrome Association (ASA), StopDuchenne, MATIO (Cystic Fibrosis Poland), Dignitas Dolentium, Finnish Neuro Society, KD-UK, HDANI, Sepsis Research FEAT, APACS/EGPA, arthritis.org.gr, Sjogren Europe, NORD, and many others.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Massive Bio: Massive Bio uses AI to match cancer patients to clinical trials globally. It is a direct peer on the patient trial matching use case and competes for the same oncology patient demand that ClinicalTrials.eu addresses.
• CenterWatch: CenterWatch is a long-established clinical trial information directory serving patients and sponsors. It is a direct peer on the trial listing and patient information use case, predating ClinicalTrials.eu but operating with less of a multilingual/European focus.
• myTomorrows: myTomorrows is a Dutch-headquartered platform that helps patients find and access clinical trials and expanded access programs, with a strong European footprint. It overlaps directly with ClinicalTrials.eu on patient trial discovery and cross-border trial access in Europe.
• Clara Health: Clara Health is a patient clinical trial matching platform with a navigator-assisted model. It serves the same patient-facing trial discovery use case as ClinicalTrials.eu, differentiated by higher-touch patient concierge services.
• Mendel: Mendel builds AI for clinical trial feasibility, patient cohort identification, and trial matching. It competes in the same AI-driven trial matching category that ClinicalTrials.eu's AI Mode targets, primarily serving sponsors and CROs.
• Antidote: Antidote operates a patient-facing clinical trial search and matching platform connecting patients to trials based on condition and location. It is the most direct functional peer to ClinicalTrials.eu, with the key difference being Antidote's broader geographic reach and deeper B2B pharma relationships versus CTIN's pan-European multilingual depth.
• Deep 6 AI (now Power): Deep 6 AI applies AI to match patients to clinical trials by mining structured and unstructured EHR data. It is comparable to ClinicalTrials.eu's AI Mode feature on the underlying matching technology, although its primary customer is the trial sponsor/site rather than the patient.

Broad incumbents

• WHO International Clinical Trials Registry Platform (ICTRP): The WHO ICTRP aggregates trial records from multiple global registries and is comparable to ClinicalTrials.eu as a multi-source clinical trial aggregation platform, although WHO ICTRP is positioned primarily for researchers and regulators rather than patients.
• EU Clinical Trials Information System (CTIS): CTIS is the European Medicines Agency's official EU clinical trial registry and a primary data source for ClinicalTrials.eu. As the regulator-backed registry, it is the most structurally important incumbent — any expansion of its patient-facing capabilities would directly compete with CTIN's curation layer.
• ClinicalTrials.gov: ClinicalTrials.gov is the US National Library of Medicine's official clinical trial registry and a primary global data source that ClinicalTrials.eu aggregates alongside EU sources. It is a broad incumbent in clinical trial information — operating at much larger scale but with no patient-friendly multilingual UX layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trials Information Network